Proteolysis Targeting Chimera Degraders of the METTL3–14 m6A‑RNA Methyltransferase

Proteolysis Targeting Chimera Degraders of the METTL3–14 m6A‑RNA Methyltransferase

Bibliographic Details
Main Authors:	Francesco Errani, Annalisa Invernizzi, Marcin Herok, Elena Bochenkova, Fiona Stamm, Ivan Corbeski, Valeria Romanucci, Giovanni Di Fabio, František Zálešák, Amedeo Caflisch
Format:	Article
Language:	English
Published:	American Chemical Society 2024-02-01
Series:	JACS Au
Online Access:	https://doi.org/10.1021/jacsau.4c00040

Similar Items

The catalytic mechanism of the RNA methyltransferase METTL3
by: Ivan Corbeski, et al.
Published: (2024-03-01)

Small-Molecule Inhibitors of the m7G-RNA Writer METTL1
by: Francesco Nai, et al.
Published: (2023-12-01)

Proteolysis-targeting chimeras (PROTACs) in cancer therapy
by: Xinyi Li, et al.
Published: (2022-04-01)

Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis
by: Tian-Ping Zhang, et al.
Published: (2022-12-01)

Solution structure of the RNA recognition domain of METTL3-METTL14 N6-methyladenosine methyltransferase
by: Jinbo Huang, et al.
Published: (2018-03-01)

Computer aided drug design in the development of proteolysis targeting chimeras
by: Tin M. Tunjic, et al.
Published: (2023-01-01)

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
by: Rui Li, et al.
Published: (2022-12-01)

Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
by: Satoshi Yamanaka, et al.
Published: (2023-08-01)

Increased N6-methyladenosine is related to the promotion of the methyltransferase METTL14 in ovarian aging
by: Chunfeng Qian, et al.
Published: (2024-05-01)

Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras
by: Tianzhi Wen, et al.
Published: (2023-05-01)

Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
by: Rekha Tamatam, et al.
Published: (2023-03-01)

Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier
by: Toshihiko Tashima
Published: (2023-06-01)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
by: Yujeong Moon, et al.
Published: (2023-01-01)

Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease
by: Fengxia Guo, et al.
Published: (2023-06-01)

A Mechanistic Pharmacodynamic Modeling Framework for the Assessment and Optimization of Proteolysis Targeting Chimeras (PROTACs)
by: Robin Thomas Ulrich Haid, et al.
Published: (2023-01-01)

MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
by: André T. S. Vicente, et al.
Published: (2022-09-01)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
by: Orazio Angelo Arcidiacono, et al.
Published: (2020-10-01)

Methyltransferase-like (METTL) homologues participate in Nicotiana benthamiana antiviral responses
by: Jianying Yue, et al.
Published: (2023-12-01)

The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer
by: Daisy B. Haigh, et al.
Published: (2022-10-01)

The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms
by: Yuxiang Zhang, et al.
Published: (2023-03-01)

Oral lipid nanocomplex of BRD4 PROteolysis TArgeting Chimera and vemurafenib for drug-resistant malignant melanoma
by: Aishwarya Saraswat, et al.
Published: (2023-12-01)

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
by: Yu-Ling Tseng, et al.
Published: (2023-04-01)

Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
by: Guliang Yang, et al.
Published: (2022-03-01)

Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
by: Yang Zhou, et al.
Published: (2023-08-01)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
by: Yeqiu Xu, et al.
Published: (2023-05-01)

Design, Synthesis, and Biological Evaluation of Proteolysis Targeting Chimeras (PROTACs) for the Dual Degradation of IGF-1R and Src
by: Sudhakar Manda, et al.
Published: (2020-04-01)

From classic medicinal chemistry to state‐of‐the‐art interdisciplinary medicine: Recent advances in proteolysis‐targeting chimeras technology
by: Xuyang Zhao, et al.
Published: (2023-04-01)

The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes
by: Davydova, E, et al.
Published: (2021)

The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target
by: Xuming Zhou, et al.
Published: (2024-01-01)

METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function
by: Agnieszka Ruszkowska
Published: (2021-02-01)

Correction: Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
by: Yeqiu Xu, et al.
Published: (2023-06-01)

Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
by: Popat Mohite, et al.
Published: (2024-02-01)

Design, Synthesis, and Antitumor Activity Evaluation of Proteolysis-Targeting Chimeras as Degraders of Extracellular Signal-Regulated Kinases 1/2
by: Pengming Pan, et al.
Published: (2023-11-01)

METTL4 is an snRNA m6Am methyltransferase that regulates RNA splicing
by: Chen, H, et al.
Published: (2020)

RNA m6A methyltransferase METTL14 promotes the procession of non‐small cell lung cancer by targeted CSF1R
by: Siying Ren, et al.
Published: (2023-01-01)

Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
by: Salma Darwish, et al.
Published: (2022-07-01)

Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancerResearch in context
by: Chiu-Lien Hung, et al.
Published: (2023-04-01)

Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis
by: Hae Rim Jung, et al.
Published: (2024-02-01)

RNA Methyltransferase METTL16’s Protein Domains Have Differential Functional Effects on Cell Processes
by: Emily S. Talic, et al.
Published: (2023-06-01)

Structure, Activity and Function of the Dual Protein Lysine and Protein N-Terminal Methyltransferase METTL13
by: Magnus E. Jakobsson
Published: (2021-10-01)